Delays in Cancer Surgery Due to COVID-19 Could Harm Survival
FRIDAY, May 22, 2020 (HealthDay News) — Modest delays in cancer surgery due to the COVID-19...
Read More
Hematology/Oncology
Melanoma Risk From Biologic Therapy Remains Uncertain
THURSDAY, May 21, 2020 (HealthDay News) — Clinically important increases in melanoma risk in...
Read More Local-Stage Prostate Cancer Incidence Rates Continue to Drop
WEDNESDAY, May 20, 2020 (HealthDay News) — Prostate cancer incidence rates decreased from...
Read More Sales of Johnson’s Baby Powder Halted in U.S., Canada
WEDNESDAY, May 20, 2020 (HealthDay News) — Lawsuits claiming that talc-based Johnson’s...
Read More Multiple Genes Predispose Black Women to Breast Cancer
WEDNESDAY, May 20, 2020 (HealthDay News) — Multiple genes predispose African-American (AA)...
Read More High BMI in Childhood May Up Risk for Bladder Cancer as Adult
WEDNESDAY, May 20, 2020 (HealthDay News) — Childhood body mass index (BMI) is positively...
Read More 11.2 Percent of Pediatric Cancer Patients Positive for SARS-CoV-2
WEDNESDAY, May 20, 2020 (HealthDay News) — Among pediatric cancer patients, overall...
Read More Excessive Drinking Seen in Some Patients With Chronic Conditions
WEDNESDAY, May 20, 2020 (HealthDay News) — Among those reporting alcohol use, patients with...
Read MoreAACR 2020: Pre-existing ESR1 Mutations Predict Endocrine Therapy Failure & Poor Survival
Despite research suggesting that mutation in ESR1 is an acquired mechanism of resistance to endocrine therapy (ET), the impact of this mutation on therapy response in primary breast cancer remains unclear. To better understand...
Read More- 1
- 2